O. John Semmes

Papers

Total Citations

H-Index

About

O. John Semmes is a prominent researcher in the field of clinical proteomics, with a particular focus on cancer biomarker discovery and the application of mass spectrometry technologies to cancer diagnostics. His work has significantly advanced the understanding of how protein expression profiling can be harnessed to identify disease markers in complex biological fluids such as serum and plasma. Semmes has made notable contributions through his development and refinement of high-throughput methodologies, including MALDI/SELDI protein profiling and immobilized trypsin bead approaches combined with MALDI-TOF/TOF mass spectrometry, enabling researchers to navigate the extraordinary complexity of the serum proteome with greater precision. His 2008 paper on MALDI/SELDI serum profiling for cancer biomarker identification has garnered 22 citations, reflecting its value to the proteomics community, while his complementary work on mass spectrometry's role in cancer diagnostics has helped define the conceptual and technical boundaries of the field. By bridging molecular biology, clinical science, and computational analysis, Semmes has helped establish proteomics as a credible and powerful tool in the pursuit of early cancer detection and improved diagnostics, making his research essential reading for students and scientists working at the intersection of oncology and analytical biochemistry.